CLAIM CARD
Mechanistically, the anti-glycation properties of carnosine may relate to cognitive outcomes through protection against advanced glycation end-product (AGE) accumulation in neural tissue, a pathway implicated in neurodegeneration. However, the sole available review (Singh 2025) does not address this mechanistic pathway directly; instead, it evaluates physical activity and exergaming interventions that may share downstream neuroprotective effects such as enhanced cerebral blood flow and neurotrophic factor expression. Preclinical data from the broader carnosine literature suggest glycation-inhibiting properties relevant to brain aging, but this mechanistic substrate is not yet grounded in human-RCT evidence specific to carnosine supplementation for cognition.
Evidence grade: exploratory
Contradiction status: none
Publication: 9f7abff5-de87-4959-b080-10eac9863ba7
Provenance: Derivation Web chain
Citation Support
source_1Movahedian 2025source_2Kopytek 2025source_3Kabthymer 2024source_4Li 2025source_5Dahlen 2025